financetom
Business
financetom
/
Business
/
Veritex Q4 Non-GAAP Earnings Drop, Revenue Rises; Dividend Kept Steady
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Veritex Q4 Non-GAAP Earnings Drop, Revenue Rises; Dividend Kept Steady
Jan 28, 2025 2:34 PM

05:09 PM EST, 01/28/2025 (MT Newswires) -- Veritex ( VBTX ) late Tuesday reported Q4 non-GAAP operating earnings of $0.54 per diluted share, down from $0.58 a year ago.

Analysts polled by FactSet expected $0.55.

Revenue, expressed as the sum of net interest income and total noninterest income, was $106.2 million for the quarter ended Dec. 31, up from $77.7 million a year earlier.

Analysts expected $112.2 million.

The bank company kept its quarterly dividend steady at $0.20 per share, payable Feb. 28 to shareholders of record on Feb. 14.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Siteone Landscape Supply Insider Sold Shares Worth $540,000, According to a Recent SEC Filing
Siteone Landscape Supply Insider Sold Shares Worth $540,000, According to a Recent SEC Filing
Mar 11, 2024
04:13 PM EDT, 03/11/2024 (MT Newswires) -- John T Guthrie, Executive Vice President, CFO and Assistant Secretary, on March 08, 2024, sold 3,000 shares in Siteone Landscape Supply ( SITE ) for $540,000. Following the Form 4 filing with the SEC, Guthrie has control over a total of 15,467 shares of the company, with 15,467 shares held directly. SEC Filing:...
Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study
Acadia Pharmaceuticals' schizophrenia drug fails in late-stage study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday its experimental drug to treat negative symptoms of schizophrenia failed to meet the main goal in a late-stage study. (Reporting by Mariam Sunny in Bengaluru) ...
Universal Health Services Insider Sold Shares Worth $6,188,630, According to a Recent SEC Filing
Universal Health Services Insider Sold Shares Worth $6,188,630, According to a Recent SEC Filing
Mar 11, 2024
04:12 PM EDT, 03/11/2024 (MT Newswires) -- Steve Filton, Executive Vice President & CFO, on March 07, 2024, sold 35,000 shares in Universal Health Services ( UHS ) for $6,188,630. Following the Form 4 filing with the SEC, Filton has control over a total of 229,785 shares of the company, with 68,785 shares held directly and 161,000 controlled indirectly. SEC...
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing
Mar 11, 2024
04:12 PM EDT, 03/11/2024 (MT Newswires) -- Sean C. Flynn, Senior Vice President, General Counsel, on March 08, 2024, sold 8,115 shares in Vericel ( VCEL ) for $367,853. Following the Form 4 filing with the SEC, Flynn has control over a total of 167 shares of the company, with 167 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/887359/000114036124012608/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved